Nagaoka A - Search Results

1

GSK-3 inhibition in vitro and in vivo enhances antitumor effect of sorafenib in renal cell carcinoma (RCC).

Kawazoe H, Bilim VN, Ugolkov AV, Yuuki K, Naito S, Nagaoka A, Kato T, Tomita Y. Kawazoe H, et al. Among authors: nagaoka a. Biochem Biophys Res Commun. 2012 Jul 6;423(3):490-5. doi: 10.1016/j.bbrc.2012.05.147. Epub 2012 Jun 5. Biochem Biophys Res Commun. 2012. PMID: 22683636

2

Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.

Naito S, Bilim V, Yuuki K, Ugolkov A, Motoyama T, Nagaoka A, Kato T, Tomita Y. Naito S, et al. Among authors: nagaoka a. Clin Cancer Res. 2010 Nov 1;16(21):5124-32. doi: 10.1158/1078-0432.CCR-10-0275. Epub 2010 Oct 1. Clin Cancer Res. 2010. PMID: 20889919

3

Re-expression of miR-199a suppresses renal cancer cell proliferation and survival by targeting GSK-3β.

Tsukigi M, Bilim V, Yuuki K, Ugolkov A, Naito S, Nagaoka A, Kato T, Motoyama T, Tomita Y. Tsukigi M, et al. Among authors: nagaoka a. Cancer Lett. 2012 Feb 28;315(2):189-97. doi: 10.1016/j.canlet.2011.10.008. Epub 2011 Oct 10. Cancer Lett. 2012. PMID: 22093618

4

GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.

Ito H, Ichiyanagi O, Naito S, Bilim VN, Tomita Y, Kato T, Nagaoka A, Tsuchiya N. Ito H, et al. Among authors: nagaoka a. BMC Cancer. 2016 Jul 7;16:393. doi: 10.1186/s12885-016-2418-7. BMC Cancer. 2016. PMID: 27387559 Free PMC article.

5

Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis.

Bilim V, Yuuki K, Itoi T, Muto A, Kato T, Nagaoka A, Motoyama T, Tomita Y. Bilim V, et al. Among authors: nagaoka a. Br J Cancer. 2008 Mar 11;98(5):941-9. doi: 10.1038/sj.bjc.6604268. Epub 2008 Feb 19. Br J Cancer. 2008. PMID: 18283311 Free PMC article.

6

Bacillus Calmette-Guerin and BCG cell wall skeleton suppressed viability of bladder cancer cells in vitro.

Kato T, Bilim V, Yuuki K, Naito S, Yamanobe T, Nagaoka A, Yano I, Akaza H, Tomita Y. Kato T, et al. Among authors: nagaoka a. Anticancer Res. 2010 Oct;30(10):4089-96. Anticancer Res. 2010. PMID: 21036724

7

[Successful treatment of a case of advanced adult Wilms' tumor with pre-surgical chemotherapy, irradiation and radical nephrectomy].

Yamagishi A, Sakurai T, Naito S, Tsukigi M, Kato T, Nagaoka A, Tomita Y, Iwaba A, Yamakawa M. Yamagishi A, et al. Among authors: nagaoka a. Hinyokika Kiyo. 2011 Apr;57(4):189-92. Hinyokika Kiyo. 2011. PMID: 21646849 Free article. Japanese.

8

[Biomarker of prostate cancer--present status and future].

Nagaoka A, Tomita Y. Nagaoka A, et al. Nihon Rinsho. 2011 Jun;69 Suppl 5:126-8. Nihon Rinsho. 2011. PMID: 22207956 Review. Japanese. No abstract available.

9

[Extracorporeal partial nephrectomy and auto-transplantation after presurgical targeted therapy with tyrosine kinase inhibitors for renal cell cancer].

Nishida H, Kanno H, Hosoya N, Sakurai T, Mashima E, Naito S, Kawazoe H, Kato T, Nagaoka A, Iwaba A, Yamakawa M, Tomita Y. Nishida H, et al. Among authors: nagaoka a. Hinyokika Kiyo. 2013 Aug;59(8):507-11. Hinyokika Kiyo. 2013. PMID: 23995527 Free article. Japanese.

10

Renoprotective Procedures with a Cold Ischemia Time of <60 min Minimize the Deterioration of Kidney Function in Open Nephron-Sparing Surgery for Renal Cell Carcinoma.

Nishida H, Yamagishi A, Yagi M, Kanno H, Kurota Y, Sakurai T, Naito S, Shibasaki T, Kawazoe H, Ichiyanagi O, Kato T, Nagaoka A, Tomita Y, Tsuchiya N. Nishida H, et al. Among authors: nagaoka a. Urol Int. 2017;99(3):283-289. doi: 10.1159/000479037. Epub 2017 Jul 20. Urol Int. 2017. PMID: 28723695

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters